Type IV Collagen Is Transcriptionally Regulated by Smad1 under Advanced Glycation End Product (AGE) Stimulation

This publication has 41 references indexed in Scilit:

• Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)
  The Lancet, 1998
• Suppression of accelerated diabetic atherosclerosis by the soluble receptor for advanced glycation endproducts
  Nature Medicine, 1998
• Advanced glycation end products modulate transcriptional regulation in mesangial cells
  Kidney International, 1996
• Advanced glycation end products induce glomerular sclerosis and albuminuria in normal rats.
  Proceedings of the National Academy of Sciences, 1994
• Advanced glycation end products up-regulate gene expression found in diabetic glomerular disease.
  Proceedings of the National Academy of Sciences, 1994
• The Effect of Intensive Treatment of Diabetes on the Development and Progression of Long-Term Complications in Insulin-Dependent Diabetes Mellitus
  New England Journal of Medicine, 1993
• Aminoguanidine treatment increases elasticity and decreases fluid filtration of large arteries from diabetic rats.
  Journal of Clinical Investigation, 1993
• Exogenous advanced glycosylation end products induce complex vascular dysfunction in normal animals: a model for diabetic and aging complications.
  Proceedings of the National Academy of Sciences, 1992
• Receptor-specific increase in extracellular matrix production in mouse mesangial cells by advanced glycosylation end products is mediated via platelet-derived growth factor.
  Proceedings of the National Academy of Sciences, 1992
• Advanced Glycosylation End Products in Tissue and the Biochemical Basis of Diabetic Complications
  New England Journal of Medicine, 1988